[Photocoagulation in diabetes mellitus--our results]

Area of Science:

• Ophthalmology
• Diabetology
• Medical Retina

Background:

• Diabetic retinopathy is a leading cause of vision loss in diabetic patients.
• The study population included 56 patients aged 25-74 with a mean diabetes duration of 14 years.
• Patients presented with various stages of diabetic eye disease, including angiopathy, exudative retinopathy, and proliferative retinopathy.

Purpose of the Study:

• To evaluate the efficacy of xenon-arc photocoagulation in managing diabetic retinopathy.
• To assess the impact of photocoagulation on disease progression and visual acuity.

Main Methods:

• Fifty-six diabetic patients underwent ophthalmological examination and treatment.
• Photocoagulation using a xenon-arc lamp was performed on all affected eyes.
• Treatment modalities included focused and panretinal photocoagulation based on disease severity.

Main Results:

• Xenon-arc photocoagulation was applied to eyes exhibiting diabetic angiopathy, exudative retinopathy, and proliferative retinopathy.
• The majority of patients experienced a halt in the progression of diabetic fundus changes.
• Fair visual acuity was preserved in most cases following treatment.

Conclusions:

• Xenon-arc photocoagulation is an effective treatment for diabetic retinopathy.
• The procedure helps to stop the advancement of diabetic eye disease and maintain good vision.
• Photocoagulation offers a viable therapeutic option for preserving sight in diabetic individuals.